These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12653880)

  • 21. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Heyde's enigma" in a patient with congenital annular aortic stenosis and its therapeutic challenges.
    Manjappa M; Kumar D; Devananda NS
    Indian J Thorac Cardiovasc Surg; 2024 May; 40(3):373-376. PubMed ID: 38681706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyanoacrylate for septal ablation in hypertrophic cardiomyopathy.
    Oto A; Aytemir K; Okutucu S; Kaya EB; Deniz A; Cil B; Peynircioglu B; Kabakci G
    J Interv Cardiol; 2011 Feb; 24(1):77-84. PubMed ID: 20973822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Commentary and re-appraisal: surgical septal myectomy vs. alcohol ablation: after a decade of controversy and mismatch between clinical practice and guidelines.
    Maron BJ
    Prog Cardiovasc Dis; 2012; 54(6):523-8. PubMed ID: 22687595
    [No Abstract]   [Full Text] [Related]  

  • 25. Intracavitary pressure wire and intravascular ultrasound for the evaluation of combined symmetric hypertrophic cardiomyopathy and aortic stenosis in a patient with dyspnea and syncope: treatment with ethanol septal ablation.
    Wykrzykowska JJ; Piazza G; Laham RJ
    J Invasive Cardiol; 2008 May; 20(5):E171-3. PubMed ID: 18460722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent Gastrointestinal Angiodysplasia in Heyde's Syndrome after Aortic Valve Replacement.
    Akutagawa T; Shindo T; Yamanouchi K; Hayakawa M; Ureshino H; Tsuruoka N; Sakata Y; Shimoda R; Noguchi R; Furukawa K; Morita S; Iwakiri R; Kimura S; Matsumoto M; Fujimoto K
    Intern Med; 2017 Sep; 56(18):2431-2433. PubMed ID: 28824071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful coronary stenting of the left anterior descending artery at the branching site of the targeted septal perforator immediately after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Honda T; Sakamoto T; Miyamoto S; Sugiyama S; Yoshimura M; Ogawa H
    Intern Med; 2005 Jul; 44(7):722-6. PubMed ID: 16093594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heyde's syndrome.
    İlkeli E; Albeyoğlu Ş; Çiloğlu U; Sabri D
    Asian Cardiovasc Thorac Ann; 2014 Jun; 22(5):592-4. PubMed ID: 24867036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained ventricular tachycardia following alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Simon RD; Crawford FA; Spencer WH; Gold MR
    Pacing Clin Electrophysiol; 2005 Dec; 28(12):1354-6. PubMed ID: 16403169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic management of hypertrophic obstructive cardiomyopathy: alcohol septal ablation or surgical myomectomy?
    Noble S; Sigwart U
    Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1041-4. PubMed ID: 25039895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Jassal DS; Neilan TG; Fifer MA; Palacios IF; Lowry PA; Vlahakes GJ; Picard MH; Yoerger DM
    Eur Heart J; 2006 Aug; 27(15):1805-10. PubMed ID: 16774986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tools & techniques: Alcohol septal ablation for hypertrophic cardiomyopathy.
    Bertog SC; Franke J; Hornung M; Hofmann I; Sievert H
    EuroIntervention; 2011 Dec; 7(8):1004-5. PubMed ID: 22157484
    [No Abstract]   [Full Text] [Related]  

  • 33. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy.
    Chang SM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF
    Circulation; 2004 Feb; 109(7):824-7. PubMed ID: 14967729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
    Alam M; Dokainish H; Lakkis N
    J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe Gastrointestinal Bleeding in a Patient With Subvalvular Aortic Stenosis Treated With Thalidomide and Octreotide: Bridging to Transcoronary Ablation of Septal Hypertrophy.
    Hvid-Jensen HS; Poulsen SH; Agnholt JS
    J Clin Med Res; 2015 Nov; 7(11):907-10. PubMed ID: 26491506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Choice of Septal Reduction Therapies and Alcohol Septal Ablation.
    Fifer MA
    Cardiol Clin; 2019 Feb; 37(1):83-93. PubMed ID: 30447719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of percutaneous intervention for patients with obstructive hypertrophic cardiomyopathy and coronary artery disease.
    Nambi V; Buergler JM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF
    Am J Cardiol; 2005 Aug; 96(4):580-1. PubMed ID: 16098315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of aortic stenosis and gastrointestinal bleeding (Heyde's syndrome). Report of two cases.
    Natowitz L; Defraigne JO; Limet R
    Acta Chir Belg; 1993; 93(1):31-3. PubMed ID: 8470439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Percutaneous transluminal septal ablation with ethanol in hypertrophic obstructive cardiomyopathy: a case report].
    Sakakibara M; Abe S; Fusegawa Y; Nakajima T; Iwata O; Goto S; Shiina Y; Handa S
    J Cardiol; 1999 Jul; 34(1):35-40. PubMed ID: 10422624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of left ventricular diastolic function in obstructive hypertrophic cardiomyopathy in patients undergoing percutaneous septal alcohol ablation versus surgical myotomy/myectomy.
    Sitges M; Shiota T; Lever HM; Qin JX; Bauer F; Drinko JK; Agler DA; Martin MG; Greenberg NL; Smedira NG; Lytle BW; Tuzcu EM; Garcia MJ; Thomas JD
    Am J Cardiol; 2003 Apr; 91(7):817-21. PubMed ID: 12667567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.